Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
4.680
-0.320 (-6.40%)
At close: Nov 3, 2025, 4:00 PM EST
4.680
0.00 (0.00%)
After-hours: Nov 3, 2025, 4:10 PM EST
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $48.68 million as of November 3, 2025. Its market cap has decreased by -18.91% in one year.
Market Cap
48.68M
Enterprise Value
47.01M
1-Year Change
-18.91%
Ranking
Category
Stock Price
$4.68
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $48.68M, a decrease of -61.09%. That is a compound annual growth rate of -44.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 52.69M | 11.97% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |